Stroke : 卒中患者,出院后,他们康复如何?

2021-11-01 Freeman MedSci原创

该研究的重要意义提供了一套基于专家共识的关键因素,在确定脑卒中患者出院后护理的地点时需要考虑

在美国,每年有80万人受到中风的影响。鉴于三分之二的中风患者需要康复服务,急性后护理在患者的康复中起着关键作用。在美国,急性期后的康复护理通常由住院康复机构(IRF)或专业护理机构(SNF)提供。

与大多数SNF相比,IRF通常提供更密集的康复治疗、护理和医生护理。然而,IRF的费用较高,一些中风幸存者无法参与或受益于这种水平的康复治疗,或在任何一种设施中都能得到满意的恢复。患者的出院目的地(IRF、SNF或家庭)与他们的功能恢复和急性期再入院率有关。最近的一项研究发现,在控制了临床差异和转诊偏差后,在IRF接受急性期后护理的病人与在SNF接受护理的病人相比,功能增益更大。

然而,确定急性期后护理水平的标准仍然是主观的,应用也不一致,哪些病人被分流到IRF或SNF,有重叠的地方。缺乏一个有效的决策支持工具来进行急性期后护理的决策,导致了实践中的差异性。非临床因素,如地点、床位的可用性、病人/家属的偏好或保险,已被证明有助于决策。

一些研究对影响急性期后护理目的地的项目进行了分类(例如,移动状态、认知功能、以前的生活环境、功能依赖/疾病、人口因素)。其他研究探讨了使用标准化的评估,即对卒中严重程度、日常生活活动、活动能力和认知能力的测量,以确定哪些因素最能预测急性期后的护理水平。功能测量,如Barthel指数或功能独立测量,已被用来可靠地区分可以回家与急性后护理的中风幸存者,然而,它们并不能持续区分转入SNF与IRF的患者。

哥伦比亚大学的Joel Stein等人,主利用德尔菲法(Delphi method)就影响急性后护理级别选择的因素取得专家共识。德尔菲法是一个结构化和反复的过程,在没有黄金标准的情况下,通过专家小组达成共识。德尔菲法已经在其他各种与健康护理有关的研究中成功实施。这些研究涉及发展临床共识,确定评估病人出院准备的标准,以及在众多学科(麻醉、慢性肺阻塞性疾病、中风、颈动脉狭窄等)中建立临床指南。

他们采用了4轮德尔菲合作过程,以获得一份影响急性期后护理级别选择的精炼因素清单。德尔菲专家小组由32名小组成员组成,包括医生、物理治疗师、职业治疗师、语言病理学家、护士、中风幸存者、行政人员、政策专家和与第三方保险公司有关的个人。

在第一轮中,提出了207个因素,经过讨论后,合并为15个因素供考虑。在第二轮中,对15个因素进行了排序,并就10个因素达成了共识;

在第三轮中,对10个因素进行了排序,并就9个因素达成了共识。在第四轮,即最后一轮,对9个因素进行评级,李克特评分从5(最重要)到1(不重要)不等。提供4分或以上评分的小组成员的百分比如下。

从积极的康复计划中受益的可能性(97%),需要具有专业康复技能的临床医生(94%),需要积极和持续的医疗管理和监测(84%),容忍积极康复计划的能力(74%),需要照顾者培训以返回社区(48%),家庭/照顾者支持(39%),返回社区/家庭的可能性(39%),返回实际家庭环境的能力(32%),以及病前痴呆症(16%)。

该研究的重要意义提供了一套基于专家共识的关键因素,在确定脑卒中患者出院后护理的地点时需要考虑。这些因素可能对开发临床使用的决策支持工具有帮助。

原文出处:
Stein J, Rodstein BM, Levine SR, et al. Which Road to Recovery?: Factors Influencing Postacute Stroke Discharge Destinations: A Delphi Study. Stroke. Published online October 28, 2021:STROKEAHA.121.034815. doi:10.1161/STROKEAHA.121.034815

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720424, encodeId=4e6b1e204249b, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Nov 26 10:19:25 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065714, encodeId=34201065e148e, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aed85623248, createdName=ms2000000160907340, createdTime=Mon Nov 01 09:20:10 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065704, encodeId=77e61065e047f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Nov 01 09:08:30 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065696, encodeId=79b91065696da, content=近的一项研究发现,在控制了临床差异, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Nov 01 08:58:24 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065688, encodeId=83b7106568837, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/43a1d57f79934b84a056879057182725/76af758a9a5f4b4cbf97fff2aae3cb15.jpg, createdBy=e03e5535659, createdName=夕火, createdTime=Mon Nov 01 08:25:29 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1720424, encodeId=4e6b1e204249b, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Nov 26 10:19:25 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065714, encodeId=34201065e148e, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aed85623248, createdName=ms2000000160907340, createdTime=Mon Nov 01 09:20:10 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065704, encodeId=77e61065e047f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Nov 01 09:08:30 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065696, encodeId=79b91065696da, content=近的一项研究发现,在控制了临床差异, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Nov 01 08:58:24 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065688, encodeId=83b7106568837, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/43a1d57f79934b84a056879057182725/76af758a9a5f4b4cbf97fff2aae3cb15.jpg, createdBy=e03e5535659, createdName=夕火, createdTime=Mon Nov 01 08:25:29 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-01 ms2000000160907340

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1720424, encodeId=4e6b1e204249b, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Nov 26 10:19:25 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065714, encodeId=34201065e148e, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aed85623248, createdName=ms2000000160907340, createdTime=Mon Nov 01 09:20:10 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065704, encodeId=77e61065e047f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Nov 01 09:08:30 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065696, encodeId=79b91065696da, content=近的一项研究发现,在控制了临床差异, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Nov 01 08:58:24 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065688, encodeId=83b7106568837, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/43a1d57f79934b84a056879057182725/76af758a9a5f4b4cbf97fff2aae3cb15.jpg, createdBy=e03e5535659, createdName=夕火, createdTime=Mon Nov 01 08:25:29 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-01 MaYazhen

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1720424, encodeId=4e6b1e204249b, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Nov 26 10:19:25 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065714, encodeId=34201065e148e, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aed85623248, createdName=ms2000000160907340, createdTime=Mon Nov 01 09:20:10 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065704, encodeId=77e61065e047f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Nov 01 09:08:30 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065696, encodeId=79b91065696da, content=近的一项研究发现,在控制了临床差异, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Nov 01 08:58:24 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065688, encodeId=83b7106568837, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/43a1d57f79934b84a056879057182725/76af758a9a5f4b4cbf97fff2aae3cb15.jpg, createdBy=e03e5535659, createdName=夕火, createdTime=Mon Nov 01 08:25:29 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-01 查查佳佳

    近的一项研究发现,在控制了临床差异

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1720424, encodeId=4e6b1e204249b, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Nov 26 10:19:25 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065714, encodeId=34201065e148e, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aed85623248, createdName=ms2000000160907340, createdTime=Mon Nov 01 09:20:10 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065704, encodeId=77e61065e047f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/880c1c6388a746ba9d119bfcdc861297/62661b3226e441b08d535541976faa6a.jpg, createdBy=d42d2088603, createdName=MaYazhen, createdTime=Mon Nov 01 09:08:30 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065696, encodeId=79b91065696da, content=近的一项研究发现,在控制了临床差异, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Nov 01 08:58:24 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065688, encodeId=83b7106568837, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/43a1d57f79934b84a056879057182725/76af758a9a5f4b4cbf97fff2aae3cb15.jpg, createdBy=e03e5535659, createdName=夕火, createdTime=Mon Nov 01 08:25:29 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
    2021-11-01 夕火

    #学习#学习学习

    0

相关资讯

JNNP:急性功能性假性卒中与轻度急性缺血性卒中的长期随访比较

每年都有许多患者因怀疑患有急性缺血性中风(AIS)而入住急诊室。有几种情况可以表现为急性中风样症状,其中最常见的是癫痫发作、偏头痛和功能紊乱。后者被称为假性功能性中风(FSM)。虽然AIS患者的预后已

Neurology:模拟实测下,神经病学研究生处理急性缺血性卒中能否令人满意?

模拟实测下, 神经学研究生在急性缺血性中风的初始治疗中表现令人放心,但在溶栓后出血转化的治疗中经常出错,这表明需要围绕这一低频率、高敏锐度的事件进行更多的教育。

JAHA:急性失代偿性心衰患者缺血性卒中

在ADHF住院期间,1.6%的患者发生缺血性卒中。男性、ACS、既往心衰住院和入院时高BNP/NT-proBNP水平与缺血性卒中独立相关。

Stroke:阿司匹林治疗失败的缺血性卒中患者抗血栓治疗可预防卒中

在接受阿司匹林预防性治疗的缺血性卒中患者中,近一半患者出院时使用阿司匹林单药治疗,而没有改变抗血栓药物类别,而另一半出院时使用氯吡格雷单药治疗、双联抗血小板治疗或其他不太常见的药物治疗。

脑出血后何时重启抗血小板治疗?

抗血小板治疗是缺血性卒中和冠状动脉疾病一级和二级预防的基石。

Lancet Neurol:难分伯仲——非免疫原性重组葡激酶与阿尔替普酶治疗急性缺血性卒中患者的比较(FRIDA)

对于急性缺血性卒中患者,非免疫原性葡激酶的疗效不逊于阿尔替普酶。病死率、症状性颅内出血和严重不良事件在各组之间没有显著差异,其在4.5h时间窗内治疗急性缺血性卒中的安全性和有效性有待进一步研究。

拓展阅读

脑梗死、脑出血、脑卒中、脑中风是一回事儿吗?

脑死.脑出血.脑卒中.脑中风,鉴别,解析。

STROKE:中国学者:坐姿太极拳来啦,能为中风患者提供更有效的功能恢复!

研究结果支持量身定制的坐姿太极拳项目对改善亚急性中风幸存者的康复效果

stroke:家族患蛛网膜下腔出血,新评分可辅助预测个人SAH风险

对于有≥2个受影响的一级亲属的人,NASH评分改善了目前的预测

Stroke:血管内治疗,美国黑人和白人是否有区别?

血管内治疗(EVT)对选定的大血管闭塞(LVO)急性缺血性卒中(AIS)患者来说是一种非常有影响的治疗方法。

Stroke:多模态神经影像和行为数据,可预测脑中风语言康复治疗

中风后静止状态下的大脑功能连接是预测治疗反应性的一个特别重要的因素

Stroke:伴房颤的虚弱患者,抗凝治疗预后更好

在体弱的房颤患者中,OAC治疗与积极的净临床结果有关